IMA - Ikena Oncology, Inc.
5.81
-0.190 -3.270%
Share volume: 30,083
Last Updated: 04-21-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.00
-0.19
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-13-2024 | 08-08-2024 | 11-07-2024 | 03-06-2025 | 05-08-2025 | 07-24-2025 | 11-12-2025 | 03-10-2026 | |
| Assets | |||||||||
| Total Assets | 172.782 M | 157.485 M | 148.988 M | 141.510 M | 130.838 M | 126.166 M | 160.878 M | 152.976 M | |
| Current Assets | 161.166 M | 149.321 M | 141.533 M | 127.169 M | 116.999 M | 99.013 M | 147.532 M | 140.288 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 104.497 M | 101.151 M | 92.843 M | 84.993 M | 77.288 M | 37.352 M | 39.421 M | 40.817 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 52.852 M | 44.268 M | 45.190 M | 39.393 M | 36.763 M | 58.290 M | 103.162 M | 94.532 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 864.000 K | 772.000 K | 682.000 K | 593.000 K | 506.000 K | 419.000 K | 0.000 | 0.000 | |
| Other Assets | 10.752 M | 7.392 M | 6.773 M | 13.748 M | 13.333 M | 26.734 M | 13.346 M | 12.688 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 172.782 M | 157.485 M | 148.988 M | 141.510 M | 130.838 M | 126.166 M | 160.878 M | 152.976 M | |
| Total liabilities | 17.435 M | 14.626 M | 14.756 M | 15.576 M | 12.588 M | 10.259 M | 21.046 M | 19.837 M | |
| Total current liabilities | 10.169 M | 8.196 M | 9.240 M | 10.778 M | 8.793 M | 7.324 M | 11.144 M | 11.234 M | |
| Accounts Payable | 1.909 M | 1.408 M | 1.540 M | 897.000 K | 805.000 K | 512.000 K | 2.081 M | 1.439 M | |
| Other liabilities | 7.266 M | 6.430 M | 5.516 M | 3.737 M | 3.795 M | 2.935 M | 9.902 M | 8.603 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 1.061 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 7.266 M | 6.430 M | 5.516 M | 3.737 M | 3.795 M | 2.935 M | 9.902 M | 8.603 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 155.347 M | 142.859 M | 134.232 M | 125.934 M | 118.250 M | 115.907 M | 139.832 M | 133.139 M | |
| Common stock | 454.191 M | 455.470 M | 456.487 M | 457.485 M | 458.389 M | 458.847 M | 362.881 M | 363.105 M | |
| Retained earnings | -298.531 M | -312.261 M | -322.495 M | -331.619 M | -340.238 M | -343.005 M | -223.143 M | -230.053 M |